Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01.10.2012 | Article

Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study

verfasst von: D. A. Barr, L. Semple, R. A. Seaton

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Despite increasing use, limited data has been published comparing safety of different outpatient parenteral antimicrobial therapy (OPAT) models. Potential risks of self-administration at home include venous access device infection and other line complications. This study aims to investigate rates and predictors of intravenous access device complications in a large OPAT cohort. This is a retrospective cohort study of all uses of midlines, peripherally inserted central catheters (PICCs) and tunnelled central venous catheters (TCVCs) with univariate and multivariate (logistic regression) analysis of factors associated with line infections (LIs) and with other line events (OLEs). On univariate analysis, line infections were associated with length of line use, female sex and TCVC lines (compared to midlines). Patients self-administering OPAT in the home had a non-significantly lower rate of LIs. On multivariate analysis only duration of line use was a significant predictor of LIs—OR 1.012 (95%CI 1.001–1.023). For OLEs, multivariate analysis suggested that only line type and use of flucloxacillin were significant explanatory variables. In this cohort, there is no evidence that self-administration of OPAT is associated with higher rates of venous access device complications after controlling for confounding variables.
Literatur
1.
Zurück zum Zitat Esposito S, Noviello S, Leone S et al (2004) Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob 24(5):473–478CrossRef Esposito S, Noviello S, Leone S et al (2004) Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob 24(5):473–478CrossRef
2.
Zurück zum Zitat Paladino JA, Poretz D (2010) Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 51(Suppl 2):S198–S208PubMedCrossRef Paladino JA, Poretz D (2010) Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 51(Suppl 2):S198–S208PubMedCrossRef
3.
Zurück zum Zitat Upton A, Ellis-Pegler RB, Woodhouse A (2004) Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. N Z Med J 117(1200):U1020PubMed Upton A, Ellis-Pegler RB, Woodhouse A (2004) Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital. N Z Med J 117(1200):U1020PubMed
4.
Zurück zum Zitat Kieran J, O'Reilly A, Parker J, Clarke S, Bergin C (2009) Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis 28(11):1369–1374PubMedCrossRef Kieran J, O'Reilly A, Parker J, Clarke S, Bergin C (2009) Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting. Eur J Clin Microbiol Infect Dis 28(11):1369–1374PubMedCrossRef
5.
Zurück zum Zitat Gilchrist M, Franklin BD, Patel JP (2008) An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 62(1):177–183PubMedCrossRef Gilchrist M, Franklin BD, Patel JP (2008) An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 62(1):177–183PubMedCrossRef
6.
Zurück zum Zitat Matthews PC, Conlon CP, Berendt AR et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60(2):356–362PubMedCrossRef Matthews PC, Conlon CP, Berendt AR et al (2007) Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 60(2):356–362PubMedCrossRef
7.
Zurück zum Zitat Dougherty L, Bravery K, Gabriel J et al (2010) Standards for infusion therapy, 3rd edn. Royal College of Nursing, London Dougherty L, Bravery K, Gabriel J et al (2010) Standards for infusion therapy, 3rd edn. Royal College of Nursing, London
8.
Zurück zum Zitat Barr DA, Semple L, Seaton RA. (2012) Outpatient parenteral antimicrobial therapy in a teaching hospital based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicro Ag. doi:10.1016/j.ijantimicag.2012.01.016 Barr DA, Semple L, Seaton RA. (2012) Outpatient parenteral antimicrobial therapy in a teaching hospital based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicro Ag. doi:10.​1016/​j.​ijantimicag.​2012.​01.​016
9.
Zurück zum Zitat Roszell S, Jones C (2010) Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J Infus Nurs 33(2):112–118PubMedCrossRef Roszell S, Jones C (2010) Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J Infus Nurs 33(2):112–118PubMedCrossRef
10.
Zurück zum Zitat Lanbeck P, Odenholt I, Paulsen O (2002) Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis 34(7):512–519PubMedCrossRef Lanbeck P, Odenholt I, Paulsen O (2002) Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis 34(7):512–519PubMedCrossRef
11.
Zurück zum Zitat Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45PubMedCrossRef
12.
Zurück zum Zitat Lam S, Scannell R, Roessler D, Smith MA (1994) Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med 154(16):1833–1837PubMedCrossRef Lam S, Scannell R, Roessler D, Smith MA (1994) Peripherally inserted central catheters in an acute-care hospital. Arch Intern Med 154(16):1833–1837PubMedCrossRef
13.
Zurück zum Zitat Goodwin ML, Carlson I (1993) The peripherally inserted central catheter: a retrospective look at three years of insertions. J Intraven Nurs 16(2):92–103PubMed Goodwin ML, Carlson I (1993) The peripherally inserted central catheter: a retrospective look at three years of insertions. J Intraven Nurs 16(2):92–103PubMed
14.
Zurück zum Zitat Funk D, Gray J, Plourde PJ (2001) Two-year trends of peripherally inserted central catheter-line complications at a tertiary-care hospital: role of nursing expertise. Infect Control Hosp Epidemiol 22(6):377–379PubMedCrossRef Funk D, Gray J, Plourde PJ (2001) Two-year trends of peripherally inserted central catheter-line complications at a tertiary-care hospital: role of nursing expertise. Infect Control Hosp Epidemiol 22(6):377–379PubMedCrossRef
15.
Zurück zum Zitat Loewenthal MR, Dobson PM, Starkey RE, Dagg SA, Petersen A, Boyle MJ (2002) The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion. Anaesth Intensive Care 30(1):21–24PubMed Loewenthal MR, Dobson PM, Starkey RE, Dagg SA, Petersen A, Boyle MJ (2002) The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion. Anaesth Intensive Care 30(1):21–24PubMed
16.
Zurück zum Zitat Mermel LA, Parenteau S, Tow SM (1995) The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med 123(11):841–844PubMed Mermel LA, Parenteau S, Tow SM (1995) The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med 123(11):841–844PubMed
17.
Zurück zum Zitat Cummings M, Hearse N, McCutcheon H, Deuter K (2011) Improving antibiotic treatment outcomes through the implementation of a midline: piloting a change in practice for cystic fibrosis patients. J Vasc Nurs 29(1):11–15PubMedCrossRef Cummings M, Hearse N, McCutcheon H, Deuter K (2011) Improving antibiotic treatment outcomes through the implementation of a midline: piloting a change in practice for cystic fibrosis patients. J Vasc Nurs 29(1):11–15PubMedCrossRef
18.
Zurück zum Zitat Goetz AM, Miller J, Wagener MM, Muder RR (1998) Complications related to intravenous midline catheter usage. A 2-year study. J Intraven Nurs 21(2):76–80PubMed Goetz AM, Miller J, Wagener MM, Muder RR (1998) Complications related to intravenous midline catheter usage. A 2-year study. J Intraven Nurs 21(2):76–80PubMed
19.
Zurück zum Zitat Pikwer A, Akeson J, Lindgren S (2011) Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 67(1):65–71PubMedCrossRef Pikwer A, Akeson J, Lindgren S (2011) Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 67(1):65–71PubMedCrossRef
20.
Zurück zum Zitat Moureau N, Poole S, Murdock MA, Gray SM, Semba CP (2002) Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 13(10):1009–1016PubMedCrossRef Moureau N, Poole S, Murdock MA, Gray SM, Semba CP (2002) Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 13(10):1009–1016PubMedCrossRef
21.
22.
Zurück zum Zitat Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81(9):1159–1171PubMedCrossRef Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81(9):1159–1171PubMedCrossRef
23.
Zurück zum Zitat Tokars JI, Cookson ST, McArthur MA, Boyer CL, McGeer AJ, Jarvis WR (1999) Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 131(5):340–347PubMed Tokars JI, Cookson ST, McArthur MA, Boyer CL, McGeer AJ, Jarvis WR (1999) Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 131(5):340–347PubMed
24.
Zurück zum Zitat Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMedCrossRef Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMedCrossRef
25.
Zurück zum Zitat Amodeo MR, Clulow T, Lainchbury J et al (2009) Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect 59(6):387–393PubMedCrossRef Amodeo MR, Clulow T, Lainchbury J et al (2009) Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect 59(6):387–393PubMedCrossRef
26.
Zurück zum Zitat Bernard L, El H, Pron B et al (2001) Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 26(6):445–451PubMedCrossRef Bernard L, El H, Pron B et al (2001) Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost. J Clin Pharm Ther 26(6):445–451PubMedCrossRef
27.
Zurück zum Zitat Fisher DA, Kurup A, Lye D et al (2006) Outpatient parenteral antibiotic therapy in Singapore. Int J Antimicrob Agents 28(6):545–550PubMedCrossRef Fisher DA, Kurup A, Lye D et al (2006) Outpatient parenteral antibiotic therapy in Singapore. Int J Antimicrob Agents 28(6):545–550PubMedCrossRef
28.
Zurück zum Zitat Hitchcock J, Jepson AP, Main J, Wickens HJ (2009) Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series. J Antimicrob Chemother 64(3):630–634PubMedCrossRef Hitchcock J, Jepson AP, Main J, Wickens HJ (2009) Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series. J Antimicrob Chemother 64(3):630–634PubMedCrossRef
29.
Zurück zum Zitat Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE (1999) Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 106(1):44–49PubMedCrossRef Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE (1999) Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 106(1):44–49PubMedCrossRef
30.
Zurück zum Zitat Lin JW, Kacker A, Anand VK, Levine H (2005) Catheter- and antibiotic-related complications of ambulatory intravenous antibiotic therapy for chronic refractory rhinosinusitis. Am J Rhinol 19(4):365–369PubMed Lin JW, Kacker A, Anand VK, Levine H (2005) Catheter- and antibiotic-related complications of ambulatory intravenous antibiotic therapy for chronic refractory rhinosinusitis. Am J Rhinol 19(4):365–369PubMed
31.
Zurück zum Zitat Nathwani D (2001) The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy 47(Suppl 1):17–23PubMedCrossRef Nathwani D (2001) The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy 47(Suppl 1):17–23PubMedCrossRef
Metadaten
Titel
Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study
verfasst von
D. A. Barr
L. Semple
R. A. Seaton
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1604-z

Weitere Artikel der Ausgabe 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.